McNeil HP, Simpson RJ, Chesterman CN, Krilis SAAnti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apoliprotein H). Proc Natl Acad Sci USA1990; 87: 4120-4124.
4.
Galli M., Comfurius P., Maassen HC et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet1990 ; 335: 1544-1547.
5.
Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Koike T.Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease . Lancet1990; 336: 177-178.
6.
Hashimoto Y. , Kawamura M., Ichikawa K. et al. Anticardiolipin antibodies in NZW X BXSB F1 mice: a model of antiphospholipid syndrome. J Immunol1992; 149: 1063-1068.
7.
Kita Y., Sumida T., Iawamoto I., Yoshida S., Toike T.V gene analysis of anticardiolipin antibodies from (NZW X BXSB)F1 mice. Immunology (in press).
8.
Harris EN, Gharavi AE, Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematous. Lancet1983; ii: 1211-1214.
9.
Koike T., Sueishi M., Funaki H., Tomioka H., Yoshida S.Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol1984; 56: 193-199.
10.
Matsuura E., Igarashi Y., Fujimoto M. et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol1992; 148: 3885-3891.
11.
Koike T., Matsuura E.What is the `true' antigen for anticardiolipin antibodies?Lancet1991; 337: 671-672.
12.
Matsuura E., Igarashi Y., Yasuda T., Triplett DA, Koike T.Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med1994; 179: 457-462.
13.
Matsuura E. , Igarashi M., Igarashi Y., Naage H. et al. Molecular definition of human β2-glycoprotein I (β2-GPI) by cDNA cloning and inter-species differences of β2-GPI in alteration of anticardiolipin binding . Int Immunol1991; 3: 1217-1221.
14.
Schultze HE , Heide H., Haupt H.Uber ein Bisher Unbekanntes Niedermolekulares β2-globulin des Humanserums. Naturwissenschaften1961; 48: 719-723.
15.
Lozier J., Takahashi N., Putnam FWComplete amino acid sequence of human β2-glycoprotein IProc Natl Acad Sci USA1984; 81: 3640-3644.
16.
Kato H., Enjgoji K.Amino acid sequence and location of the disulfide bonds in bovine β2-glycoprotein I: the presence of five Sushi domains. Biochemistry1991; 30: 11687-11694.
17.
Hang LM, Izui S., Dixon FJ(NZB X BXSB) F1 hybrid, a model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med1981 ; 154: 216-221.
18.
Berden Jhm, Hang LM, McConahey PJ, Dixon FJAnalysis of vascular lesions in murine SLE. I. Association with serological abnormalities. J Immunol1983 ; 130: 1699-1705.
19.
Hang LM, Stephen-Larson PM, Henry JP, Dixon FJThe role of hypertension in the vascular disease and myocardial infarcts associated with murine systemic lupus erythematosus. Arthritis Rheum1983; 26: 1340-1345.
20.
Hang LM, Stephen-Larson PM, Henry JP, Dixon FJTransfer of renovascular hypertension and coronary heart disease by lymphoid cells from SLE-prone mice. Am J Pathol1984 ; 115: 42-46.
21.
Hudgins CC, Steinberg RT, Kilnman DM, Reeves Mjp, Steinberg ADStudies of consomic mice bearing the Y chromosome of the BXSB mouse . J Imunol1985; 134: 3849-3854.
22.
Cerny A., Starobinski M., Hugin AW, Sutter S., Zinkemagel RM, Izui S.Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW × BXSB) F1 hybrid mice. J Immunol1987; 138: 4222-4228.
23.
Yoshida H., Fujiwara H., Fujiwara T., Ikehara S., Hamashima Y. Quantitative analysis of myocardial infarction in (NZW × BXSB) F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. Am J Pathol1987 ; 129: 477-485.
24.
McNeil HP, Chesterman CN, Krilis SAImmunology and clinical importance of antiphospholipid antibodies . Adv Immunol1991; 49: 193-280.
25.
Oyizu N., Yasumizu R., Miyama-Inaba M. et al. (NZW X BXSB) F1 mouse, a new animal model of idiopathic thrombocytopenic purpura. J Exp Med1988; 167: 2017-2022.
26.
Shlomchik M. , Mascelli M., Shan H. et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med1990; 171: 265-292.
27.
Shlomchik MJ , Aucoin AH, Pisetsky DS, Weigert MGStructure and function of anti-DNA autoantibodies derived from a single autoimmune mouse . Proc Natl Acad Sci USA1987; 84: 9150-9154.
28.
Van Es JH, Gmelig-Meyling Fhj, van de Akker Wrm et al. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of SLE. J Exp Med1991; 173: 461-470.
29.
Taki S., Hirose S., Kinoshita K., Nishimura H., Shimamura T., Hmuro J., Shirai T.Somatically mutated IgG anti-DNA antibody clonally related to germ-line encoded IgM anti-DNA antibody. Eur J Immunol1992; 22: 987-992.
30.
Kita Y., Sumida T., Ichikawa K. et al. V gene analysis of anticardiolipin antibodies from MRL-1pr/1pr mice. J Immunol1993; 151: 849-856.
31.
Brodeur PH, Riblet R.The immunoglobulin heavy chain variable region (Igh V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. EurJ Imunol1984; 14: 922-930.
32.
Potter M., Newell JB, Rudikoff S., Haber E.Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol1982; 19: 1619-1630.
